Georg W. Holzer

641 total citations
25 papers, 528 citations indexed

About

Georg W. Holzer is a scholar working on Genetics, Molecular Biology and Virology. According to data from OpenAlex, Georg W. Holzer has authored 25 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 11 papers in Molecular Biology and 11 papers in Virology. Recurrent topics in Georg W. Holzer's work include Virus-based gene therapy research (14 papers), Poxvirus research and outbreaks (11 papers) and Herpesvirus Infections and Treatments (6 papers). Georg W. Holzer is often cited by papers focused on Virus-based gene therapy research (14 papers), Poxvirus research and outbreaks (11 papers) and Herpesvirus Infections and Treatments (6 papers). Georg W. Holzer collaborates with scholars based in Austria, United States and Australia. Georg W. Holzer's co-authors include Falko G. Falkner, Thomas R. Kreil, Perry Barrett, Klaus K. Orlinger, Hartmut J. Ehrlich, Brian A. Crowe, Helga Savidis-Dacho, Michael G. Schwendinger, Friedrich Dorner and Otfried Kistner and has published in prestigious journals such as PLoS ONE, Journal of Virology and The Journal of Infectious Diseases.

In The Last Decade

Georg W. Holzer

25 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Georg W. Holzer Austria 13 211 190 161 159 140 25 528
Tim D. Powell United States 11 248 1.2× 114 0.6× 97 0.6× 256 1.6× 82 0.6× 14 478
Tatyana Yun United States 10 355 1.7× 397 2.1× 84 0.5× 117 0.7× 102 0.7× 14 641
W. A. M. Boere Netherlands 11 291 1.4× 143 0.8× 51 0.3× 289 1.8× 87 0.6× 17 508
Aurore Vidy France 9 397 1.9× 273 1.4× 104 0.6× 80 0.5× 186 1.3× 14 813
Jonathan R. Grover United States 13 223 1.1× 87 0.5× 65 0.4× 120 0.8× 184 1.3× 16 552
Paulo H. Verardi United States 11 167 0.8× 167 0.9× 156 1.0× 33 0.2× 114 0.8× 26 490
Lesley C. Dupuy United States 17 471 2.2× 304 1.6× 109 0.7× 216 1.4× 244 1.7× 29 819
B A Brody United States 8 148 0.7× 137 0.7× 76 0.5× 34 0.2× 118 0.8× 9 479
Charles V. Trimarchi United States 14 151 0.7× 181 1.0× 179 1.1× 98 0.6× 93 0.7× 28 574
Sung G. Kim United States 13 95 0.5× 321 1.7× 74 0.5× 62 0.4× 67 0.5× 15 529

Countries citing papers authored by Georg W. Holzer

Since Specialization
Citations

This map shows the geographic impact of Georg W. Holzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georg W. Holzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georg W. Holzer more than expected).

Fields of papers citing papers by Georg W. Holzer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georg W. Holzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georg W. Holzer. The network helps show where Georg W. Holzer may publish in the future.

Co-authorship network of co-authors of Georg W. Holzer

This figure shows the co-authorship network connecting the top 25 collaborators of Georg W. Holzer. A scholar is included among the top collaborators of Georg W. Holzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georg W. Holzer. Georg W. Holzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Holzer, Georg W., Gerald Aichinger, Helga Savidis-Dacho, et al.. (2011). Evaluation of an inactivated Ross River virus vaccine in active and passive mouse immunization models and establishment of a correlate of protection. Vaccine. 29(24). 4132–4141. 30 indexed citations
2.
Schäfer, Birgit, Georg W. Holzer, Michael G. Schwendinger, et al.. (2011). Pre-Clinical Efficacy and Safety of Experimental Vaccines Based on Non-Replicating Vaccinia Vectors against Yellow Fever. PLoS ONE. 6(9). e24505–e24505. 25 indexed citations
3.
Schäfer, Birgit, et al.. (2011). Selection of recombinant MVA by rescue of the essential D4R gene. Virology Journal. 8(1). 529–529. 7 indexed citations
4.
Aichinger, Gerald, Hartmut J. Ehrlich, John Aaskov, et al.. (2011). Safety and immunogenicity of an inactivated whole virus Vero cell-derived Ross River virus vaccine: A randomized trial. Vaccine. 29(50). 9376–9384. 1 indexed citations
5.
Orlinger, Klaus K., Richard Fritz, Georg W. Holzer, et al.. (2011). A Tick-borne Encephalitis Virus Vaccine Based on the European Prototype Strain Induces Broadly Reactive Cross-neutralizing Antibodies in Humans. The Journal of Infectious Diseases. 203(11). 1556–1564. 83 indexed citations
6.
Schwendinger, Michael G., Georg W. Holzer, Klaus K. Orlinger, et al.. (2011). Vectors Based on Modified Vaccinia Ankara Expressing Influenza H5N1 Hemagglutinin Induce Substantial Cross-Clade Protective Immunity. PLoS ONE. 6(1). e16247–e16247. 45 indexed citations
7.
Orlinger, Klaus K., Georg W. Holzer, Julia Schwaiger, et al.. (2010). An inactivated West Nile Virus vaccine derived from a chemically synthesized cDNA system. Vaccine. 28(19). 3318–3324. 21 indexed citations
8.
Schwendinger, Michael G., Georg W. Holzer, Nicolas Sabarth, et al.. (2010). A Pandemic Influenza H1N1 Live Vaccine Based on Modified Vaccinia Ankara Is Highly Immunogenic and Protects Mice in Active and Passive Immunizations. PLoS ONE. 5(8). e12217–e12217. 30 indexed citations
9.
Farcet, Maria R., et al.. (2010). Human IgG Subclasses:In VitroNeutralization of andIn VivoProtection against West Nile Virus. Journal of Virology. 85(4). 1896–1899. 36 indexed citations
10.
Holzer, Georg W., Michael G. Schwendinger, P Brühl, et al.. (2009). Nonreplicating Vaccinia Virus Vectors Expressing the H5 Influenza Virus Hemagglutinin Produced in Modified Vero Cells Induce Robust Protection. Journal of Virology. 83(10). 5192–5203. 25 indexed citations
11.
12.
Falkner, Florian & Georg W. Holzer. (2004). Vaccinia Viral / Retroviral Chimeric Vectors. Current Gene Therapy. 4(4). 417–426. 8 indexed citations
13.
Holzer, Georg W. & Falko G. Falkner. (2003). Poxviral/Retroviral Chimeric Vectors Allow Cytoplasmic Production of Transducing Defective Retroviral Particles. Humana Press eBooks. 76. 565–578. 1 indexed citations
14.
Holzer, Georg W., et al.. (2003). Overexpression of hepatitis B virus surface antigens including the preS1 region in a serum-free Chinese hamster ovary cell line. Protein Expression and Purification. 29(1). 58–69. 21 indexed citations
15.
Holzer, Georg W., et al.. (2002). Replicative retroviral vectors for cancer gene therapy. Cancer Gene Therapy. 10(1). 30–39. 64 indexed citations
16.
Holzer, Georg W., et al.. (1999). Poxviral/Retroviral Chimeric Vectors Allow Cytoplasmic Production of Transducing Defective Retroviral Particles. Virology. 253(1). 107–114. 9 indexed citations
17.
Holzer, Georg W., et al.. (1998). Dominant Host Range Selection of Vaccinia Recombinants by Rescue of an Essential Gene. Virology. 249(1). 160–166. 17 indexed citations
18.
Himly, Martin, Michael Pfleiderer, Georg W. Holzer, et al.. (1998). Defective Vaccinia Virus as a Biologically Safe Tool for the Overproduction of Recombinant Human Secretory Proteins. Protein Expression and Purification. 14(3). 317–326. 4 indexed citations
19.
Antoine, Gerhard, Friedrich Scheiflinger, Georg W. Holzer, et al.. (1996). Characterization of the vaccinia MVA hemagglutinin gene locus and its evaluation as an insertion site for foreign genes. Gene. 177(1-2). 43–46. 12 indexed citations
20.
Stober, T., К. Schimrigk, Georg W. Holzer, & Bruna Ziegler. (1983). Quantitative evaluation of functional capacity during isoniazid therapy in huntington's disease. Journal of Neurology. 229(4). 237–245. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tim D. Powell Breakdown of academic impact, for papers by Tatyana Yun Breakdown of academic impact, for papers by W. A. M. Boere Breakdown of academic impact, for papers by Aurore Vidy Breakdown of academic impact, for papers by Jonathan R. Grover Breakdown of academic impact, for papers by Paulo H. Verardi Breakdown of academic impact, for papers by Lesley C. Dupuy Breakdown of academic impact, for papers by B A Brody Breakdown of academic impact, for papers by Charles V. Trimarchi Breakdown of academic impact, for papers by Sung G. Kim
Rankless by CCL
2026